{
  "DOI": "10.1186/s40246-019-0254-y",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-019-0254-y",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eGenome-wide association studies (GWAS) have significantly contributed to the association of many clinical conditions and phenotypic characteristics with genomic variants. The majority of these genomic findings have been deposited to the GWAS catalog. So far, findings uncovering associations of single nucleotide polymorphisms (SNPs) with treatment efficacy in mood disorders are encouraging, but not adequate.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eStatistical, genomic, and literature information was retrieved from EBI’s GWAS catalog, while we also searched for potential clinical information/clinical guidelines in well-established pharmacogenomics databases regarding the assessed drug-SNP correlations of the present study.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eHere, we provide an overview of significant genome-wide associations of SNPs with the response to commonly prescribed antipsychotics and antidepressants. Up to date, this is the first study providing novel insight in previously reported pharmacogenomics associations for antipsychotic/antidepressant treatment. We also show that although there are published CPIC guidelines for antidepressant agents, as well as the FDA labels include genome-based drug prescription information for both antipsychotic and antidepressant treatments, there are no specific clinical guidelines for the assessed drug-SNP correlations of this study.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eOur present findings suggest that more effort should be implemented towards identifying GWA-significant antipsychotic and antidepressant pharmacogenomics correlations. Moreover, additional functional studies are required in order to characterise the potential role of the assessed SNPs as biomarkers for the response of patients to antipsychotic/antidepressant treatment.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "254"
  ],
  "article-number": "4",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "31 October 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "24 December 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "15 January 2020"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Not applicable"
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare no conflict of interest. GPP is Full Member and National Representative at the European Medicines Agency, Committee for Human Medicinal Products (CHMP)–Pharmacogenomics working Party in Amsterdam, the Netherlands."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Koromina",
      "given": "Maria",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Koutsilieri",
      "given": "Stefania",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-0519-7776",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Patrinos",
      "given": "George P.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        1,
        15
      ]
    ],
    "date-time": "2020-01-15T18:02:31Z",
    "timestamp": 1579111351000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        1,
        14
      ]
    ],
    "date-time": "2021-01-14T00:12:45Z",
    "timestamp": 1610583165000
  },
  "funder": [
    {
      "DOI": "10.13039/501100005302",
      "award": [
        "2017"
      ],
      "doi-asserted-by": "publisher",
      "name": "Alexander S. Onassis Public Benefit Foundation"
    },
    {
      "DOI": "10.13039/100010661",
      "award": [
        "668353"
      ],
      "doi-asserted-by": "publisher",
      "name": "Horizon 2020 Framework Programme"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        8
      ]
    ],
    "date-time": "2024-03-08T09:18:24Z",
    "timestamp": 1709889504457
  },
  "is-referenced-by-count": 7,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2020,
        1,
        15
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2020,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            1,
            15
          ]
        ],
        "date-time": "2020-01-15T00:00:00Z",
        "timestamp": 1579046400000
      }
    },
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            1,
            15
          ]
        ],
        "date-time": "2020-01-15T00:00:00Z",
        "timestamp": 1579046400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0254-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-019-0254-y/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0254-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2020,
        1,
        15
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        1,
        15
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/0049-3848(83)90353-5",
      "author": "GD Sweeney",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Thromb Res Suppl.",
      "key": "254_CR1",
      "unstructured": "Sweeney GD. Variability in the human drug response. Thromb Res Suppl. 1983;4:3–15.",
      "volume": "4",
      "year": "1983"
    },
    {
      "author": "P Westervelt",
      "first-page": "630",
      "issue": "9",
      "journal-title": "P T.",
      "key": "254_CR2",
      "unstructured": "Westervelt P, Cho K, Bright DR, Kisor DF. Drug-gene interactions: inherent variability in drug maintenance dose requirements. P T. 2014;39(9):630–7.",
      "volume": "39",
      "year": "2014"
    },
    {
      "DOI": "10.1038/s41588-019-0397-8",
      "author": "EA Stahl",
      "doi-asserted-by": "publisher",
      "first-page": "793",
      "issue": "5",
      "journal-title": "Nat Genet.",
      "key": "254_CR3",
      "unstructured": "Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51(5):793–803.",
      "volume": "51",
      "year": "2019"
    },
    {
      "DOI": "10.1016/S2215-0366(18)30049-X",
      "author": "H Yu",
      "doi-asserted-by": "publisher",
      "first-page": "327",
      "issue": "4",
      "journal-title": "Lancet Psychiatry.",
      "key": "254_CR4",
      "unstructured": "Yu H, Yan H, Wang L, Li J, Tan L, Deng W, et al. Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study. Lancet Psychiatry. 2018;5(4):327–38.",
      "volume": "5",
      "year": "2018"
    },
    {
      "DOI": "10.1186/1471-2156-14-39",
      "author": "R Patnala",
      "doi-asserted-by": "publisher",
      "first-page": "39",
      "journal-title": "BMC Genet.",
      "key": "254_CR5",
      "unstructured": "Patnala R, Clements J, Batra J. Candidate gene association studies: a comprehensive guide to useful in silico tools. BMC Genet. 2013;14:39.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1038/npp.2015.5",
      "author": "G Blasi",
      "doi-asserted-by": "publisher",
      "first-page": "1600",
      "issue": "7",
      "journal-title": "Neuropsychopharmacology.",
      "key": "254_CR6",
      "unstructured": "Blasi G, Selvaggi P, Fazio L, Antonucci LA, Taurisano P, Masellis R, et al. Variation in dopamine D2 and serotonin 5-HT2A receptor genes is associated with working memory processing and response to treatment with antipsychotics. Neuropsychopharmacology. 2015;40(7):1600–8.",
      "volume": "40",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.pnpbp.2011.11.018",
      "author": "R Hwang",
      "doi-asserted-by": "publisher",
      "first-page": "62",
      "issue": "1",
      "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry.",
      "key": "254_CR7",
      "unstructured": "Hwang R, Tiwari AK, Zai CC, Felsky D, Remington E, Wallace T, et al. Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration. Prog Neuropsychopharmacol Biol Psychiatry. 2012;37(1):62–75.",
      "volume": "37",
      "year": "2012"
    },
    {
      "DOI": "10.2217/pgs.14.158",
      "author": "JG Pouget",
      "doi-asserted-by": "publisher",
      "first-page": "5",
      "issue": "1",
      "journal-title": "Pharmacogenomics.",
      "key": "254_CR8",
      "unstructured": "Pouget JG, Goncalves VF, Nurmi EL, Laughlin CP, Mallya KS, Mc Cracken JT, et al. Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes. Pharmacogenomics. 2015;16(1):5–22.",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.biopsych.2013.03.033",
      "author": "E Bramon",
      "doi-asserted-by": "publisher",
      "first-page": "386",
      "issue": "5",
      "journal-title": "Biol Psychiatry.",
      "key": "254_CR9",
      "unstructured": "Psychosis Endophenotypes International C, Wellcome Trust Case-Control C, Bramon E, Pirinen M, Strange A, Lin K, et al. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biol Psychiatry. 2014;75(5):386–97.",
      "volume": "75",
      "year": "2014"
    },
    {
      "DOI": "10.2217/pgs-2018-0163",
      "author": "JD Allen",
      "doi-asserted-by": "publisher",
      "first-page": "291",
      "issue": "4",
      "journal-title": "Pharmacogenomics.",
      "key": "254_CR10",
      "unstructured": "Allen JD, Bishop JR. A systematic review of genome-wide association studies of antipsychotic response. Pharmacogenomics. 2019;20(4):291–306.",
      "volume": "20",
      "year": "2019"
    },
    {
      "key": "254_CR11",
      "unstructured": "Food and Drug Administration. 2019. http://www.fda.gov. Accessed 25 Oct 2019."
    },
    {
      "DOI": "10.2174/1875692111666131223235548",
      "author": "Y Cheng",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "Curr Pharmacogenomics Person Med.",
      "key": "254_CR12",
      "unstructured": "Cheng Y, He YJ, Tang J, Zhou HH. Translating pharmacogenetics and pharmacogenomics: the last 60 years and the rise of collective innovation as a force multiplier for personalized medicine. Curr Pharmacogenomics Person Med. 2014;12:15–31.",
      "volume": "12",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cpt.976",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "745",
      "issue": "5",
      "journal-title": "Clin Pharmacol Ther.",
      "key": "254_CR13",
      "unstructured": "Lauschke VM, Ingelman-Sundberg M. How to consider rare genetic variants in personalized drug therapy. Clin Pharmacol Ther. 2018;103(5):745–8.",
      "volume": "103",
      "year": "2018"
    },
    {
      "key": "254_CR14",
      "unstructured": "Food and Drug Administration. Table of pharmacogenic biomarkers in drug labeling. In: Science and and research drugs. Food and Drug Administration. 2019. https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling. Accessed 25 Oct 2019."
    },
    {
      "key": "254_CR15",
      "unstructured": "Clinical Pharmacogenetics Implementation Consortium. (2019). https://cpicpgx.org. Accessed 25 Oct 2019."
    },
    {
      "DOI": "10.1007/978-3-319-24277-4",
      "author": "H Wickham",
      "doi-asserted-by": "publisher",
      "key": "254_CR16",
      "unstructured": "Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer-Verlag; 2016.",
      "volume-title": "ggplot2: elegant graphics for data analysis",
      "year": "2016"
    },
    {
      "DOI": "10.21105/joss.00731",
      "doi-asserted-by": "crossref",
      "key": "254_CR17",
      "unstructured": "Turner, S.D. qqman: an R package for visualizing GWAS results using Q-Q and manhattan plots. J Open Source Softw. 2018;3(25):731."
    },
    {
      "DOI": "10.1038/s41588-018-0059-2",
      "author": "AF Pardiñas",
      "doi-asserted-by": "publisher",
      "first-page": "381",
      "issue": "3",
      "journal-title": "Nat Genet.",
      "key": "254_CR18",
      "unstructured": "Pardiñas AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50(3):381–9.",
      "volume": "50",
      "year": "2018"
    },
    {
      "DOI": "10.1001/jama.2014.7859",
      "author": "WH Chung",
      "doi-asserted-by": "publisher",
      "first-page": "525",
      "issue": "5",
      "journal-title": "JAMA.",
      "key": "254_CR19",
      "unstructured": "Chung WH, Chang WC, Lee YS, Wu YY, Yang CH, Ho HC, et al. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA. 2014;312(5):525–34.",
      "volume": "312",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S2215-0366(19)30088-4",
      "author": "MM Jukic",
      "doi-asserted-by": "publisher",
      "first-page": "418",
      "issue": "5",
      "journal-title": "Lancet Psychiatry.",
      "key": "254_CR20",
      "unstructured": "Jukic MM, Smith RL, Haslemo T, Molden E, Ingelman-Sundberg M. Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study. Lancet Psychiatry. 2019;6(5):418–26.",
      "volume": "6",
      "year": "2019"
    },
    {
      "DOI": "10.1002/cpt.725",
      "author": "CH van der Wouden",
      "doi-asserted-by": "publisher",
      "first-page": "152",
      "issue": "1",
      "journal-title": "Clin Pharmacol Ther.",
      "key": "254_CR21",
      "unstructured": "van der Wouden CH, Cambon-Thomsen A, Cecchin E, Cheung KC, Davila-Fajardo CL, Deneer VH, et al. CORRIGENDUM: implementing pharmacogenomics in Europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium. Clin Pharmacol Ther. 2017;102(1):152.",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41576-019-0127-1",
      "author": "V Tam",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "issue": "8",
      "journal-title": "Nat Rev Genet.",
      "key": "254_CR22",
      "unstructured": "Tam V, Patel N, Turcotte M, Bosse Y, Pare G, Meyre D. Benefits and limitations of genome-wide association studies. Nat Rev Genet. 2019;20(8):467–84.",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.1093/nar/gky1120",
      "author": "A Buniello",
      "doi-asserted-by": "publisher",
      "first-page": "D1005",
      "issue": "Database issue",
      "journal-title": "Nucleic Acids Res",
      "key": "254_CR23",
      "unstructured": "Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, et al. The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(Database issue):D1005–12.",
      "volume": "47",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.schres.2018.04.006",
      "author": "J Li",
      "doi-asserted-by": "publisher",
      "first-page": "203",
      "journal-title": "Schizophr Res.",
      "key": "254_CR24",
      "unstructured": "Li J, Loebel A, Meltzer HY. Identifying the genetic risk factors for treatment response to lurasidone by genome-wide association study: a meta-analysis of samples from three independent clinical trials. Schizophr Res. 2018;199:203–13.",
      "volume": "199",
      "year": "2018"
    },
    {
      "DOI": "10.1038/mp.2008.52",
      "author": "S Volpi",
      "doi-asserted-by": "publisher",
      "first-page": "1024",
      "issue": "11",
      "journal-title": "Mol Psychiatry.",
      "key": "254_CR25",
      "unstructured": "Volpi S, Heaton C, Mack K, Hamilton JB, Lannan R, Wolfgang CD, et al. Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia. Mol Psychiatry. 2009;14(11):1024–31.",
      "volume": "14",
      "year": "2009"
    },
    {
      "DOI": "10.1038/mp.2009.89",
      "author": "JL McClay",
      "doi-asserted-by": "publisher",
      "first-page": "76",
      "issue": "1",
      "journal-title": "Mol Psychiatry.",
      "key": "254_CR26",
      "unstructured": "McClay JL, Adkins DE, Aberg K, Stroup S, Perkins DO, Vladimirov VI, et al. Genome-wide pharmacogenomics analysis of response to treatment with antipsychotics. Mol Psychiatry. 2011;16(1):76–85.",
      "volume": "16",
      "year": "2011"
    },
    {
      "DOI": "10.1038/mp.2010.14",
      "author": "DE Adkins",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "issue": "3",
      "journal-title": "Mol Psychiatry.",
      "key": "254_CR27",
      "unstructured": "Adkins DE, Aberg K, McClay JL, Bukszár J, Zhao Z, Jia P, et al. Genomewide pharmacogenomics study of metabolic side effects to antipsychotic drugs. Mol Psychiatry. 2011;16(3):321–32.",
      "volume": "16",
      "year": "2011"
    },
    {
      "DOI": "10.1038/tpj.2010.76",
      "author": "K Aberg",
      "doi-asserted-by": "publisher",
      "first-page": "165",
      "issue": "2",
      "journal-title": "Pharmacogenomics J.",
      "key": "254_CR28",
      "unstructured": "Aberg K, Adkins DE, Liu Y, McClay JL, Bukszár J, Jia P, et al. Genome-wide association study of antipsychotic-induced QTc interval prolongation. Pharmacogenomics J. 2012;12(2):165–72.",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1017/S003329171100239X",
      "author": "SL Clark",
      "doi-asserted-by": "publisher",
      "first-page": "1151",
      "issue": "6",
      "journal-title": "Psychol Med",
      "key": "254_CR29",
      "unstructured": "Clark SL, Adkins DE, Aberg K, Hettema JM, McClay JL, Souza RP, et al. Pharmacogenomics study of side-effects for antidepressant treatment options in STAR*D. Psychol Med. 2012;42(6):1151–62.",
      "volume": "42",
      "year": "2012"
    },
    {
      "DOI": "10.1097/FPC.0b013e32835ca260",
      "author": "SL Clark",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "issue": "2",
      "journal-title": "Pharmacogenet Genomics.",
      "key": "254_CR30",
      "unstructured": "Clark SL, Souza RP, Adkins DE, Aberg K, Bukszár J, McClay JL, et al. Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment. Pharmacogenet Genomics. 2013;23(2):69–77.",
      "volume": "23",
      "year": "2013"
    },
    {
      "DOI": "10.1097/FPC.0000000000000052",
      "author": "A Drago",
      "doi-asserted-by": "publisher",
      "first-page": "314",
      "issue": "6",
      "journal-title": "Pharmacogenet Genomics.",
      "key": "254_CR31",
      "unstructured": "Drago A, Giegling I, Schäfer M, Hartmann AM, Konte B, Friedl M, et al. Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment. Pharmacogenet Genomics. 2014;24(6):314–9.",
      "volume": "24",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ncomms5757",
      "author": "JI Goldstein",
      "doi-asserted-by": "publisher",
      "first-page": "4757",
      "journal-title": "Nat Commun",
      "key": "254_CR32",
      "unstructured": "Goldstein JI, Jarskog LF, Hilliard C, Alfirevic A, Duncan L, Fourches D, et al. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. Nat Commun. 2014;5:4757.",
      "volume": "5",
      "year": "2014"
    },
    {
      "DOI": "10.1177/0269881115584469",
      "author": "L Athanasiu",
      "doi-asserted-by": "publisher",
      "first-page": "884",
      "issue": "8",
      "journal-title": "J Psychopharmacol",
      "key": "254_CR33",
      "unstructured": "Athanasiu L, Smorr LL, Tesli M, Røssberg JI, Sønderby IE, Spigset O, et al. Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs. J Psychopharmacol. 2015;29(8):884–91.",
      "volume": "29",
      "year": "2015"
    },
    {
      "DOI": "10.1038/tpj.2015.90",
      "author": "E Sacchetti",
      "doi-asserted-by": "publisher",
      "first-page": "146",
      "issue": "2",
      "journal-title": "Pharmacogenomics J.",
      "key": "254_CR34",
      "unstructured": "Sacchetti E, Magri C, Minelli A, Valsecchi P, Traversa M, Calza S, et al. The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis. Pharmacogenomics J. 2017;17(2):146–54.",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.biopsych.2015.12.006",
      "author": "T Saito",
      "doi-asserted-by": "publisher",
      "first-page": "636",
      "issue": "8",
      "journal-title": "Biol Psychiatry",
      "key": "254_CR35",
      "unstructured": "Saito T, Ikeda M, Mushiroda T, Ozeki T, Kondo K, Shimasaki A, et al. Pharmacogenomics study of clozapine-induced agranulocytosis/granulocytopenia in a Japanese population. Biol Psychiatry. 2016;80(8):636–42.",
      "volume": "80",
      "year": "2016"
    },
    {
      "DOI": "10.1038/mp.2016.97",
      "author": "SE Legge",
      "doi-asserted-by": "publisher",
      "first-page": "1502",
      "issue": "10",
      "journal-title": "Mol Psychiatry",
      "key": "254_CR36",
      "unstructured": "Legge SE, Hamshere ML, Ripke S, Pardinas AF, Goldstein JI, Rees E, et al. Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia. Mol Psychiatry. 2017;22(10):1502–8.",
      "volume": "22",
      "year": "2017"
    },
    {
      "DOI": "10.1038/tp.2016.168",
      "author": "KN Dodds",
      "doi-asserted-by": "publisher",
      "first-page": "e888",
      "issue": "9",
      "journal-title": "Transl Psychiatry",
      "key": "254_CR37",
      "unstructured": "Dodds KN, Beckett EA, Evans SF, Grace PM, Watkins LR, Hutchinson MR. Glial contributions to visceral pain: implications for disease etiology and the female predominance of persistent pain. Transl Psychiatry. 2016;6(9):e888.",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1038/tp.2016.171",
      "author": "QS Li",
      "doi-asserted-by": "publisher",
      "first-page": "e889",
      "issue": "9",
      "journal-title": "Transl Psychiatry",
      "key": "254_CR38",
      "unstructured": "Li QS, Tian C, Seabrook GR, Drevets WC, Narayan VA. Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. Transl Psychiatry. 2016;6(9):e889.",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1097/FPC.0000000000000250",
      "author": "Q Li",
      "doi-asserted-by": "publisher",
      "first-page": "7",
      "issue": "1",
      "journal-title": "Pharmacogenet Genomics.",
      "key": "254_CR39",
      "unstructured": "Li Q, Wineinger NE, Fu DJ, Libiger O, Alphs L, Savitz A. Genome-wide association study of paliperidone efficacy. Pharmacogenet Genomics. 2017;27(1):7–18.",
      "volume": "27",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.psychres.2017.04.025",
      "author": "J Jung",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "journal-title": "Psychiatry Res",
      "key": "254_CR40",
      "unstructured": "Jung J, Tawa EA, Muench C, Rosen AD, Rickels K, Lohoff FW. Genome-wide association study of treatment response to venlafaxine XR in generalized anxiety disorder. Psychiatry Res. 2017;254:8–11.",
      "volume": "254",
      "year": "2017"
    },
    {
      "DOI": "10.1038/tpj.2017.29",
      "author": "M Maciukiewicz",
      "doi-asserted-by": "publisher",
      "first-page": "406",
      "issue": "3",
      "journal-title": "Pharmacogenomics J",
      "key": "254_CR41",
      "unstructured": "Maciukiewicz M, Marshe VS, Tiwari AK, Fonseka TM, Freeman N, Kennedy JL, et al. Genome-wide association studies of placebo and duloxetine response in major depressive disorder. Pharmacogenomics J. 2018;18(3):406–12.",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1038/tpj.2017.30",
      "author": "TH McCoy",
      "doi-asserted-by": "publisher",
      "first-page": "347",
      "issue": "2",
      "journal-title": "Pharmacogenomics J",
      "key": "254_CR42",
      "unstructured": "McCoy TH, Castro VM, Cagan A, Snapper L, Roberson A, Perlis RH. Cytochrome P450 interactions are common and consequential in Massachusetts hospital discharges. Pharmacogenomics J. 2018;18(2):347–50.",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41398-018-0311-7",
      "author": "W Guo",
      "doi-asserted-by": "publisher",
      "first-page": "280",
      "issue": "1",
      "journal-title": "Transl Psychiatry",
      "key": "254_CR43",
      "unstructured": "Guo W, Machado-Vieira R, Mathew S, Murrough JW, Charney DS, Grunebaum M, et al. Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression. Transl Psychiatry. 2018;8(1):280.",
      "volume": "8",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41380-018-0335-7",
      "author": "SE Legge",
      "doi-asserted-by": "publisher",
      "first-page": "328",
      "issue": "3",
      "journal-title": "Mol Psychiatry",
      "key": "254_CR44",
      "unstructured": "Legge SE, Pardiñas AF, Helthuis M, Jansen JA, Jollie K, Knapper S, et al. A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia. Mol Psychiatry. 2019;24(3):328–37.",
      "volume": "24",
      "year": "2019"
    },
    {
      "DOI": "10.1002/epi4.12297",
      "author": "B Berghuis",
      "doi-asserted-by": "publisher",
      "first-page": "102",
      "issue": "1",
      "journal-title": "Epilepsia Open",
      "key": "254_CR45",
      "unstructured": "Berghuis B, Stapleton C, Sonsma ACM, Hulst J, de Haan GJ, Lindhout D, et al. A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. Epilepsia Open. 2019;4(1):102–9.",
      "volume": "4",
      "year": "2019"
    },
    {
      "DOI": "10.1176/appi.ajp.2019.18050589",
      "author": "AF Pardiñas",
      "doi-asserted-by": "publisher",
      "first-page": "477",
      "issue": "6",
      "journal-title": "Am J Psychiatry",
      "key": "254_CR46",
      "unstructured": "Pardiñas AF, Nalmpanti M, Pocklington AJ, Legge SE, Medway C, King A, et al. Pharmacogenomics variants and drug interactions identified through the genetic analysis of clozapine metabolism. Am J Psychiatry. 2019;176(6):477–86.",
      "volume": "176",
      "year": "2019"
    },
    {
      "author": "R Core Team",
      "key": "254_CR47",
      "unstructured": "Core Team R. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2019.",
      "volume-title": "R: A language and environment for statistical computing",
      "year": "2019"
    },
    {
      "key": "254_CR48",
      "unstructured": "R Project. 2019. https://www.r-project.org. Accessed 25 Oct 2019."
    },
    {
      "DOI": "10.2146/ajhp150977",
      "author": "KE Caudle",
      "doi-asserted-by": "publisher",
      "first-page": "1977",
      "issue": "23",
      "journal-title": "Am J Health Syst Pharm.",
      "key": "254_CR49",
      "unstructured": "Caudle KE, Gammal RS, Whirl-Carrillo M, Hoffman JM, Relling MV, Klein TE. Evidence and resources to implement pharmacogenetic knowledge for precision medicine. Am J Health Syst Pharm. 2016;73(23):1977–85.",
      "volume": "73",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature15817",
      "author": "MV Relling",
      "doi-asserted-by": "publisher",
      "first-page": "343",
      "issue": "7573",
      "journal-title": "Nature.",
      "key": "254_CR50",
      "unstructured": "Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526(7573):343–50.",
      "volume": "526",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ajhg.2017.06.005",
      "author": "PM Visscher",
      "doi-asserted-by": "publisher",
      "first-page": "5",
      "issue": "1",
      "journal-title": "Am J Hum Genet.",
      "key": "254_CR51",
      "unstructured": "Visscher PM, Wray NR, Zhang Q, Sklar P, McCarthy MI, Brown MA, et al. 10 Years of GWAS discovery: biology, function, and translation. Am J Hum Genet. 2017;101(1):5–22.",
      "volume": "101",
      "year": "2017"
    },
    {
      "DOI": "10.1186/1471-2288-14-34",
      "author": "JC Jakobsen",
      "doi-asserted-by": "publisher",
      "first-page": "34",
      "journal-title": "BMC Med Res Methodol",
      "key": "254_CR52",
      "unstructured": "Jakobsen JC, Gluud C, Winkel P, Lange T, Wetterslev J. The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials. BMC Med Res Methodol. 2014;14:34.",
      "volume": "14",
      "year": "2014"
    },
    {
      "key": "254_CR53",
      "unstructured": "Ensembl GRCh37. 2019. http://grch37.ensembl.org/Homo_sapiens/Tools/VEP?db=core;tl=j2bBNIwPINafz22S-5364081. Accessed 25 Oct 2019."
    },
    {
      "DOI": "10.1002/cpt.147",
      "author": "JK Hicks",
      "doi-asserted-by": "publisher",
      "first-page": "127",
      "issue": "2",
      "journal-title": "Clinical Pharmacology \u0026 Therapeutics",
      "key": "254_CR54",
      "unstructured": "Hicks JK, Bishop JR, Sangkuhl K, Müller DJ, Ji Y, Leckband SG, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015Aug;98(2):127–34.",
      "volume": "98",
      "year": "2015"
    },
    {
      "DOI": "10.1002/cpt.597",
      "author": "JK Hicks",
      "doi-asserted-by": "publisher",
      "first-page": "37",
      "issue": "1",
      "journal-title": "Clin Pharmacol Ther.",
      "key": "254_CR55",
      "unstructured": "Hicks JK, Sangkuhl K, Swen JJ, Ellingrod VL, Müller DJ, Shimoda K, et al. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther. 2017;102(1):37–44.",
      "volume": "102",
      "year": "2017"
    }
  ],
  "reference-count": 55,
  "references-count": 55,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-019-0254-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "14"
}